PSA Health Care Equipment: Olympus (7733 JT) - FY24 Test on Clean Up Operations
FY23 is proving to be a housecleaning year for Olympus, some of it undertaken proactively, such as the sale of the scientific instruments business, some of it reactively, such as recalls and write downs. Analyst Nia Dokova discusses the outlook.Olympus is a manufacturing company. Co. operates in four business segments. The Medical segment is engaged in the manufacture and sale of gastrointestinal endoscopes, surgical devices and peripheral devices for endoscopic surgery, endoscopic devices, and ultrasonic endoscopes. The Scientific Solutions segment is engaged in the manufacture and sale of biological microscopes, industrial microscopes and endoscopes, and non-destructive testing equipment. The Imaging segment is engaged in the manufacture and sale of digital cameras, IC recorders, and binoculars. The Others segment is engaged in the provision of bio-materials, system development and others.
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.